You had expressed that we would "soon" reach commercialization but It is difficult to tell where the first revenues will come from; our licensees or direct sales. While not mentioning either of the licensees so as not to cause any difficulties... am I reading this correctly that soon may be our China Venture and or one one of our licensees? We are all looking forward to either but it would be very comforting to hear that mass tests are forthcoming. Please see the below paragraphs from two seperate letters to understand where this question was derived from. Any update on either front would greatly be appreciated.

Thank You

This is from your October 10, 2008 letter

That’s no small accomplishment, but now something genuinely momentous is just around the corner. I can announce that we will soon be reaching our ultimate goal of commercializing our RECAF technology. This will allow vast numbers of people to live longer and -- just as important in a company-building sense -- BioCurex will start pulling in significant revenue

------------------------------------...

This is from your November 5, 2008 letter.

It is difficult to tell where the first revenues will come from; our licensees or direct sales, but working on all fronts in parallel maximizes our opportunities and expedites the process. To the best of our knowledge, no other technology can match this product. The profit margin should be considerable.”